Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025)

INVO Fertility has reported Preferred Stock Liabilities over the past 2 years, most recently at $4.0 million for Q1 2025.

Quarterly Preferred Stock Liabilities changed N/A to $4.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Mar 2025, changed N/A year-over-year, with the annual reading at $7.5 million for FY2024, N/A changed from the prior year.
Preferred Stock Liabilities was $4.0 million for Q1 2025 at INVO Fertility, down from $7.5 million in the prior quarter.
Over five years, Preferred Stock Liabilities peaked at $7.5 million in Q4 2024 and troughed at $4.0 million in Q1 2025.